Neurogene to Present NGN-401 Data at ESGCT Congress
Neurogene says it will present data on its NGN-401 gene therapy program for Rett syndrome at the European Society of Gene and Cell Therapy Congress.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.